Dr. Jan-Olof Brüer at Sectras Annual General Meeting: "We shall become a leading supplier within mammography"

Dr. Jan-Olof Brüer at Sectras Annual General Meeting: "We shall become a leading supplier within mammography" "We aim to become a leading supplier in the mammography market, as a result of Sectra MicroDose Mammography, our unique low-dose system. In the past year, we have made increased financial resources available for market investments and secured strategic resources through the acquisition of Mamea Imaging AB," said President and Chief Executive Officer Jan-Olof Brüer in his address to Sectra's Annual General Meeting in Linköping today, which was attended by approximately 130 shareholders. The meeting adopted the Board of Directors' proposal to pay a dividend of SEK 0.50 per share to shareholders, or a total of SEK 18,196,025.50. Thomas Ericson, Gündor Rentsch, Carl-Erik Ridderstråle and Torbjörn Kronander were re-elected to the Board. Anders Persson, M.D., Director and Member of the Board of the Center for Medical Imaging and Visualization (CMIV) at Linköping University, was elected a new Member of the Board. The Meeting authorized the Board on one or more occasions during the period up to the next Annual General Meeting to make decisions regarding the new issue of not more than 3,600,000 Series B shares. The authorization may be used on one or more occasions in connection with the implementation or financing of acquisitions of the whole or parts of companies or operations and in connection with market investments. If the authorization is fully utilized, share capital will be diluted by approximately 10% and voting rights by approximately 6%. The Meeting authorized the Board on one or more occasions during the period up to the next Annual General Meeting to make decisions regarding the repurchase and divestment of the company's own shares. The company's holding may not at any time exceed 10% of all shares in the company. The purpose is that the repurchased shares may be used in connection with the acquisition of the whole or parts of companies or operations and in connection with market investments, or in order to cover the costs that arise as a result of the company's incentive programs or in order to continuously be able to adapt the company's capital structure and thereby contribute to increasing shareholder value. The meeting adopted a proposal to issue convertible debt instruments of which a total nominal amount of not more than SEK 35 million will be directed to Group employees and SEK 3.5 million will be directed to elected external Members of the Board. The conversion price will correspond to 135% of the volume-weighted average of listed prices paid for the company's share on Stockholmsbörsen's O List during the period from August 17, 2003 through August 31, 2004. On full subscription and full conversion, the dilution effect will be 1.0% of the share capital and approximately 0.6% of the voting rights. The meeting also adopted the Board's proposal regarding the issue of not more than 40,000 additional employee stock options for the Group's personnel in the United States. If these employee stock options are fully exercised, employees will acquire shares in the company in a number corresponding to approximately 0.1% of the share capital and 0.1% of the voting rights. The meeting approved that the five largest shareholders at the end of the third quarter, 31 January 2005, appoint a Nomination Committee and that the persons represented on this committee will be named in connection with the company's interim report for the third quarter. For further information, please contact: Sectra AB, Dr. Jan-Olof Brüer, President and CEO, +46 13 23 52 09, janolof.bruer@sectra.se Visit Sectras website http://www.sectra.com Sectra's operations Sectra has its roots in Linköping Institute of Technology and is one of Sweden's fastest growing high-tech companies in IT. Since the mid-1980s, Sectra has successfully conducted development and sales of advanced medical IT and telecommunications products. Today, the business includes products in medical systems and secure communication systems. Business is conducted in eight countries with a total of 347 employees. Sales for fiscal year 2003/2004 amounted to SEK 495 million. Since March 1999, Sectra's shares have been quoted on the O list of Stockholmsbörsen (Stockholm Exchange). ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2004/06/29/20040629BIT21420/wkr0001.pdf

About Us

Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with subsidiaries in 16 countries, and operates through partners worldwide. Sales in the 2016/2017 fiscal year totaled SEK 1,141 million. The Sectra share (STO: SECT B) is quoted on the Nasdaq Stockholm exchange. For more information, visit www.sectra.com.

Subscribe

Documents & Links